Due to the complicated pathogenic pathways of coronavirus disease 2019 (COVID-19),
related medicinal therapies have remained a clinical challenge. COVID-19 highlights the …

COVID-19, first reported in late 2019, is an ongoing pandemic that has been causing
devastation across the globe. Although there are multiple vaccines that can prevent severe …

Owing to the limitations of the present efforts on drug discovery against severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) and the lack of the understanding of the …

The SARS-CoV-2 pandemic, declared as a global health emergency by the WHO in
February 2020, has currently infected more than 6 million people with fatalities near 371,000 …

As the new year of 2020 approaches, an acute respiratory disease quietly caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as coronavirus …

Coronavirus disease 2019 (COVID-19), an acute onset pneumonia caused by a novel
Betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged …

With the objective of linking early findings relating to the novel SARS-CoV-2 coronavirus
with potentially informative findings from prior research literature and to promote …

COVID-19 is the name of the disease caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection that occurred in 2019. The virus–host-specific …

Coronaviruses (CoVs) are a large family of viruses responsible for the severe
pathophysiological effects on human health. The most severe outbreak includes Severe …

The whole world is still suffering substantially from the coronavirus disease 2019 (COVID-
19) outbreak. Several protein-based molecules that are associated with the Severe acute …